Clinical Characterization and Prediction of Clinical Severity of SARS-CoV-2 Infection Among US Adults Using Data From the US National COVID Cohort CollaborativeTellen D. Bennett, David A. Hanauer, Brian T. Garibaldi et al.|JAMA Network Open|2021Cited by 247
Continuation versus discontinuation of renin–angiotensin system inhibitors in patients admitted to hospital with COVID-19: a prospective, randomised, open-label trialJordana B. Cohen, Julio A. Chirinos, Thomas C. Hanff et al.|The Lancet Respiratory Medicine|2021Cited by 224
The National COVID Cohort Collaborative: Clinical Characterization and Early Severity PredictionTellen D. Bennett, Christopher G. Chute, Richard A. Moffitt et al.|medRxiv|2021Cited by 64
Application of Traditional Vaccine Development Strategies to SARS-CoV-2Halie M. Rando, Sandipan Ray, Ronan Lordan et al.|mSystems|2023Cited by 22
Randomized elimination and prolongation of ACE inhibitors and ARBs in coronavirus 2019 (REPLACE COVID) Trial ProtocolJordana B. Cohen, Julio A. Chirinos, Thomas C. Hanff et al.|Journal of Clinical Hypertension|2020Cited by 19